|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Methyldopa#Contraindications]] |
| {{Methyldopa}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==Contraindications==
| |
| | |
| Methyldopa is contraindicated in patients:
| |
| | |
| with active hepatic disease, such as [[acute hepatitis]] and active [[cirrhosis]].
| |
| with liver disorders previously associated with methyldopa therapy (see [[Methyldopa tablet warnings|WARNINGS]]).
| |
| | |
| with [[hypersensitivity ]]to any component of this product.
| |
| on therapy with monoamine oxidase ([[MAO]]) inhibitors.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METHYLDOPA TABLET [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d87d63fd-48f7-4130-af03-5e263c338fe4 | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |